Progression of diabetic tractional retinal detachment following single injection of intravitreal Avastin

Eye

Volumn 22, Issue 6, 2008, Pages 862-

  Tranos, P ^a   Gemenetzi, M ^a   Papandroudis, A ^a   Chrisafis, C ^a   Papadakos, D ^a  

^a Vitreous Retina Macula Center   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; CASE REPORT; CILIARY DISK; DIABETIC RETINOPATHY; DIABETIC TRACTIONAL RETINAL DETACHMENT; DISEASE COURSE; FEMALE; HUMAN; LASER COAGULATION; LETTER; OPHTHALMOSCOPY; RETINA FOVEA; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 45449114822     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6703036     Document Type: Letter

References (3)

1. Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006; 113 (10):1695.e1-1695.e15.
2. Avery RL. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina 2006; 26 (3): 352-354.
3. Isaacs TW, Barry C. Rapid resolution of severe disc new vessels in proliferative diabetic retinopathy following a single intravitreal injection. of bevacizumab (Avastin). Clin Experiment Ophthalmol 2006; 34(8): 802-803.